So we are all familiar with Hashan’s paper written about Neuren in Feb 2022 - A de-risked biotech with 4x upside when he was working for karst peak capital.https://www.livewiremarkets.com/wires/a-de-risked-biotech-with-4x-upside#
Well, he has backed it up, and has now written an updated paper as the founder of KP Rx. You can read it here
https://www.livewiremarkets.com/wires/neuren-where-to-from-here-2024-03-23
So we are all familiar with Hashan’s paper written about Neuren...
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$20.27 |
Change
0.000(0.00%) |
Mkt cap ! $2.588B | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 10 | $22.29 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $19.26 | 1081 | 3 |
View Market Depth
| Last trade - 10.00am 04/06/2024 (20 minute delay) ? |
|
|||||
|
Last
$19.84 |
Change
0.000 ( 2.56 %) |
||||
| Open | High | Low | Volume | ||
| $20.39 | $20.46 | $19.84 | 7917 | ||
| Last updated 10.19am 04/06/2024 ? | |||||
| NEU (ASX) Chart |
Day chart unavailable